TLR1-induced chemokine production is critical for mucosal immunity against Yersinia enterocolitica

Mucosal Immunology

Volumn 6, Issue 6, 2013, Pages 1101-1109

  Sugiura, Y ^a   Kamdar, K ^b   Khakpour, S ^c   Young, G ^d   Karpus, W J ^e   DePaolo, R William ^b  

^a MIDWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; TOLL LIKE RECEPTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DENDRITIC CELL; INTESTINE EPITHELIUM; MEDIATOR RELEASE; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TH17 CELL; UPREGULATION; YERSINIA ENTEROCOLITICA; YERSINIOSIS;

ANIMALS; ANTIBODIES, BLOCKING; ANTIBODY FORMATION; CELLS, CULTURED; CHEMOKINE CCL20; CHEMOKINES; DENDRITIC CELLS; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A; INTESTINAL MUCOSA; LYMPHOCYTE ACTIVATION; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, CCR6; TH17 CELLS; TOLL-LIKE RECEPTOR 1; YERSINIA ENTEROCOLITICA; YERSINIA INFECTIONS;

EID: 84886039791     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2013.5     Document Type: Article

References (48)

1. Hooper, L.V. & Macpherson, A.J. Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat. Rev. Immunol. 10, 159-169 (2010).
2. Galan, J.E. & Curtiss, R. III Cloning and molecular characterization of genes whose products allow Salmonella typhimurium to penetrate tissue culture cells. Proc. Natl. Acad. Sci. USA 86, 6383-6387 (1989).
3. Khoramian-Falsafi, T., Harayama, S., Kutsukake, K. & Pechere, J.C. Effect of motility and chemotaxis on the invasion of Salmonella typhimurium into HeLa cells. Microb. Pathog. 9, 47-53 (1990).
4. Grassl, G.A., Bohn, E., Muller, Y., Buhler, O.T. & Autenrieth, I.B. Interaction of Yersinia enterocolitica with epithelial cells: Invasin beyond invasion. Int. J. Med. Microbiol. 293, 41-54 (2003).
5. Iwasaki, A. & Medzhitov, R. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 5, 987-995 (2004).
6. Coombes, J.L. et al. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependentmechanism. J. Exp. Med. 204, 1757-1764 (2007).
7. Matzinger, P. & Kamala, T. Tissue-based class control: The other side of tolerance. Nat. Rev. Immunol. 11, 221-230 (2011).
8. Sozzani, S., Allavena, P., Vecchi, A. Mantovani, A. The role of chemokines in the regulation of dendritic cell trafficking. J. Leukoc. Biol. 66, 1-9 (1999).
9. Ito, T., Carson,W.F.t., Cavassani, K.A., Connett, J.M. & Kunkel, S.L. CCR6 as amediator of immunity in the lung and gut. Exp. Cell Res. 317, 613-619 (2011).
10. Izadpanah, A., Dwinell, M.B., Eckmann, L., Varki, N.M. & Kagnoff, M.F. Regulated MIP-3alpha/CCL20 production by human intestinal epithelium: Mechanism for modulating mucosal immunity. Am. J. Physiol. Gastrointest. Liver Physiol. 280, G710-G719 (2001).
11. Sierro, F. et al. Flagellin stimulation of intestinal epithelial cells triggers CCL20-mediated migration of dendritic cells. Proc. Natl. Acad. Sci. USA 98, 13722-13727 (2001).
12. Gewirtz, A.T.,Navas, T.A., Lyons, S.,Godowski,P.J. Madara, J.L.Cutting edge: Bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. J. Immunol. 167, 1882-1885 (2001).
13. Baba, M. et al. Identification of CCR6, the specific receptor for a novel lymphocyte-directed CC chemokine LARC. J. Biol. Chem. 272, 14893-14898 (1997).
14. Varona, R. et al. Molecular cloning, functional characterization and mRNA expression analysis of the murine chemokine receptor CCR6 and its specific ligand MIP-3alpha. FEBS Lett. 440, 188-194 (1998).
15. Liao, F. et al. CC-chemokine receptor 6 is expressed on diverse memory subsets of T cells and determines responsiveness to macrophage inflammatory protein 3 alpha. J. Immunol. 162, 186-194 (1999).
16. Schutyser, E., Struyf, S. & Van Damme, J. The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor Rev. 14, 409-426 (2003).
17. Greaves, D.R. et al. CCR6, a CC chemokine receptor that interacts with macrophage inflammatory protein 3alpha and is highly expressed in human dendritic cells. J. Exp. Med. 186, 837-844 (1997).
18. Kallal, L.E., Schaller,M.A., Lindell, D.M., Lira, S.A. & Lukacs, N.W. CCL20/ CCR6 blockade enhances immunity to RSV by impairing recruitment of DC. Eur. J. Immunol. 40, 1042-1052 (2010).
19. Wu, Y.Y. et al. Upregulation of CCL20 and recruitment of CCR6+ gastric infiltrating lymphocytes in Helicobacter pylori gastritis. Infect. Immun. 75, 4357-4363 (2007).
20. Salazar-Gonzalez, R.M. et al. CCR6-mediated dendritic cell activation of pathogen-specific Tcells in Peyer's patches. Immunity 24, 623-632 (2006).
21. Kaser, A. et al. Increased expression of CCL20 in human inflammatory bowel disease. J. Clin. Immunol. 24, 74-85 (2004).
22. Barrett, J.C. et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat. Genet. 40, 955-962 (2008).
23. Depaolo, R.W. et al. A specific role for TLR1 in protective TH17 immunity during mucosal infection. J. Exp. Med. 209, 1437-1444 (2012).
24. Kang, J.Y. et al. Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer. Immunity 31, 873-884 (2009).
25. Omueti, K.O., Beyer, J.M., Johnson, C.M., Lyle, E.A. & Tapping, R.I. Domain exchange between human toll-like receptors 1 and 6 reveals a region required for lipopeptide discrimination. J. Biol. Chem. 280, 36616-36625 (2005).
26. Johnson, C.M. et al. Cutting edge: A common polymorphism impairs cell surface trafficking and functional responses of TLR1 but protects against leprosy. J. Immunol. 178, 7520-7524 (2007).
27. Wong, S.H. et al. Leprosy and the adaptation of human toll-like receptor 1. PLoS Pathog. 6, e1000979 (2010).
28. Melmed,G. et al. Human intestinal epithelial cells are broadly unresponsive to Toll-like receptor 2-dependent bacterial ligands: Implications for hostmicrobial interactions in the gut. J. Immunol. 170, 1406-1415 (2003).
29. Rhee, S.H., Keates, A.C., Moyer, M.P. & Pothoulakis, C. MEK is a key modulator for TLR5-induced interleukin-8 andMIP3alpha gene expression in non-Transformed human colonic epithelial cells. J. Biol. Chem. 279, 25179-25188 (2004).
30. Kingma, S.D. et al. Lactobacillus johnsonii N6.2 stimulates the innate immune response through Toll-like receptor 9 in Caco-2 cells and increases intestinal crypt Paneth cell number in biobreeding diabetesprone rats. J. Nutr. 141, 1023-1028 (2011).
31. Shang, L. et al. Toll-like receptor signaling in small intestinal epithelium promotes B-cell recruitment and IgA production in lamina propria. Gastroenterology 135, 529-538 (2008).
32. Cornelis, G.R. The Yersinia Ysc-Yop 'type III' weaponry. Nat. Rev. Mol. Cell. Biol. 3, 742-752 (2002).
33. Matsumoto, H. & Young, G.M. Translocated effectors of Yersinia. Curr. Opin. Microbiol. 12, 94-100 (2009).
34. Viboud, G.I. & Bliska, J.B. Yersinia outer proteins: Role in modulation of host cell signaling responses and pathogenesis. Annu. Rev. Microbiol. 59, 69-89 (2005).
35. Brodsky, I.E. et al. A Yersinia effector protein promotes virulence by preventing inflammasome recognition of the type III secretion system. Cell Host Microbe 7, 376-387 (2010).
36. Depaolo, R.W. et al. Toll-like receptor 6 drives differentiation of tolerogenic dendritic cells and contributes to LcrV-mediated plague pathogenesis. Cell Host Microbe 4, 350-361 (2008).
37. Mueller,C.A. et al. The V-Antigen of Yersinia forms a distinct structure at the tip of injectisome needles. Science 310, 674-676 (2005).
38. Sibartie, S. et al. Modulation of pathogen-induced CCL20 secretion from HT-29 human intestinal epithelial cells by commensal bacteria. BMC Immunol. 10, 54 (2009).
39. Jaffar, Z., Ferrini, M.E., Herritt, L.A. & Roberts, K. Cutting edge: Lung mucosal Th17-mediated responses induce polymeric Ig receptor expression by the airway epithelium and elevate secretory IgA levels. J. Immunol. 182, 4507-4511 (2009).
40. Sansonetti, P.J. & Phalipon, A. M cells as ports of entry for enteroinvasive pathogens: Mechanisms of interaction, consequences for the disease process. Semin. Immunol. 11, 193-203 (1999).
41. Khan, M.A. et al. Flagellin-dependent and -independent inflammatory responses following infection by enteropathogenic Escherichia coli and Citrobacter rodentium. Infect. Immun. 76, 1410-1422 (2008).
42. Mellits, K.H. et al. Induction of a chemoattractant transcriptional response by a Campylobacter jejuni boiled cell extract in colonocytes. BMC Microbiol. 9, 28 (2009).
43. Park, S.J. et al. Neutropenia enhances lung dendritic cell recruitment in response to Aspergillus via a cytokine-To-chemokine amplification loop. J. Immunol. 185, 6190-6197 (2010).
44. Pierik, M. et al. Toll-like receptor-1, -2, and -6 polymorphisms influence disease extension in inflammatory bowel diseases. Inflamm. BowelDis. 12, 1-8 (2006).
45. Wang, S. et al. MyD88-dependent TLR1/2 signals educate dendritic cells with gut-specific imprinting properties. J. Immunol. 187, 141-150 (2011).
46. Podolsky,D.K., Gerken, G., Eyking, A.Cario, E. Colitis-Associated variant of TLR2 causes impaired mucosal repair because of TFF3 deficiency. Gastroenterology 137, 209-220 (2009).
47. Cario, E., Gerken, G. & Podolsky, D.K. Toll-like receptor 2 enhances ZO-1-Associated intestinal epithelial barrier integrity via protein kinase C. Gastroenterology 127, 224-238 (2004).
48. DePaolo, R.W. et al. Co-Adjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigens. Nature 471, 220-224 (2011).